Skip to main content
Clinical Trials/NCT02429817
NCT02429817
Completed
Not Applicable

Tomographic Comparison of Aerosol Lung Distribution With Two Nebulizers Through a High Flow Nasal Cannula

Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 site in 1 country6 target enrollmentApril 2015

Overview

Phase
Not Applicable
Intervention
Technetium-99m - Diethylenetriaminepentaacetic acid
Conditions
Healthy
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Enrollment
6
Locations
1
Primary Endpoint
Pulmonary deposition
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Vibrating-mesh nebulizers ensure currently the best deposition output and are recommended in routine use in intensive care unit. However, jet nebulizers remain the most frequently used nebulizers.

On a bench study, aerosol delivery through a high flow nasal cannula (HFNC) was increased using a vibrating-mesh nebulizer as compared to a jet nebulizer.

Lung distribution of nebulized particles delivered through a HFNC has never been investigated in vivo. The aim of this study was to compare aerosol lung distribution with both nebulizers through a HFNC by SPECT-CT.

Registry
clinicaltrials.gov
Start Date
April 2015
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy respiratory function

Exclusion Criteria

  • Pulmonary disease

Arms & Interventions

Aeroneb Solo

Subjects inhaled radiolabelled aerosol via the Aeroneb Solo connected to the high flow nasal cannula.

Intervention: Technetium-99m - Diethylenetriaminepentaacetic acid

Aeroneb Solo

Subjects inhaled radiolabelled aerosol via the Aeroneb Solo connected to the high flow nasal cannula.

Intervention: Aeroneb Solo

Aeroneb Solo

Subjects inhaled radiolabelled aerosol via the Aeroneb Solo connected to the high flow nasal cannula.

Intervention: Single photon emission computed tomography

Aeroneb Solo

Subjects inhaled radiolabelled aerosol via the Aeroneb Solo connected to the high flow nasal cannula.

Intervention: Spirometry

Standard Jet Nebulizer

Subjects inhaled radiolabelled aerosol via the jet nebulizer connected to the high flow nasal cannula.

Intervention: Technetium-99m - Diethylenetriaminepentaacetic acid

Standard Jet Nebulizer

Subjects inhaled radiolabelled aerosol via the jet nebulizer connected to the high flow nasal cannula.

Intervention: Jet Nebulizer

Standard Jet Nebulizer

Subjects inhaled radiolabelled aerosol via the jet nebulizer connected to the high flow nasal cannula.

Intervention: Single photon emission computed tomography

Standard Jet Nebulizer

Subjects inhaled radiolabelled aerosol via the jet nebulizer connected to the high flow nasal cannula.

Intervention: Spirometry

Outcomes

Primary Outcomes

Pulmonary deposition

Time Frame: Immediately after nebulization by imaging technique, expected average of 15 minutes

Single photon emission tomography combined with a CT-scan

Secondary Outcomes

  • Three-dimensional penetration index(immediately after the nebulization by imaging assessment, expected average of 30 minutes)

Study Sites (1)

Loading locations...

Similar Trials